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1. Introduction 
During the past few years, the biocompatibility of biomaterials (non-vital material intended 
to interact with biological systems within or on the human body) has evolved into a 
comprehensive, complex, and independent discipline of biomaterials science. Consequently, 
a number of terms have been developed or were adopted from toxicology. Some of these 
terms may be familiar to patients and clinicians from daily life – for example, the term 
“safety”. Safety in relation to the evaluation of biomaterials means freedom from 
unacceptable risks. Thus, safety does not stand for a complete lack of risks. 
2. Biocompatibility 
2.1 Definition of biocompatibility 
Biocompatibility is a word that is extensively used within biomaterials science, but there still 
exists a great deal of uncertainty about what it actually means and about the mechanisms 
that are subsumed within the phenomena that collectively constitute biocompatibility. 
During the 2nd Consensus Conference in Liverpool, biocompatibility was defined as “the 
ability of a material to perform with an appropriate host response in a specific application” 
(Gatti & Knowles, 2002, as cited in 2nd Consensus Conference, 1991). A biocompatible 
material may not be completely “inert”; in fact, the appropriateness of the host response is 
decisive. Previously, the selection criteria for implantable biomaterials evolved as a list of 
events that had to be avoided, most of these originating from those events associated with 
the release of some products of corrosion or degradation, or additives to or contaminants of 
the main constituents of the biomaterial, and their subsequent biological activity, either 
locally or systemically. Materials were therefore selected, or occasionally developed, on the 
basis that they would be non-toxic, non-immunogenic, non-thrombogenic, non-
carcinogenic, non-irritant and so on, such a list of negatives becoming, by default, the 
definition of biocompatibility. A re-evaluation of this position was initiated by two 
important factors. Firstly, an increasing number of applications required that the material 
should specifically react with the tissues rather than be ignored by them, as required in the 
case of an inert material. Secondly, and in a similar context, some applications required that 
the material should degrade over time in the body rather than remain indefinitely.  It was 
therefore considered that the very basic edict that biocompatibility, which was equated with 
biological safety, meant that the material should do no harm to the patient, was no longer a 
sufficient pre-requisite. Accordingly, biocompatibility was redefined in 2008 as “the ability 
of a material to perform its desired function with respect to a medical therapy, without 
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eliciting any undesirable local or systemic effects in the recipient or beneficiary of that 
therapy, but generating the most appropriate beneficial cellular or tissue response in that 
specific situation, and optimizing the clinically relevant performance of that therapy” 
(Williams, 2008). 
2.2 Components of biocompatibility 
In addition to the beneficial tissue response and the clinically relevant performance of a 
biomaterial, cytotoxicity, genotoxicity, mutagenicity, carcinogenicity and immunogenicity 
are considered to be the components which constitute “biocompatibility” (Table 1). 
 
Beneficial tissue response and the clinically relevant performance 
Cytotoxicity (systemic and local) 
Genotoxicity 
Mutagenicity 
Carcinogenicity 
Immunogenicity 
Table 1. Components of biocompatibility 
Toxicity of a material describes the ability to damage a biological system by chemical means. 
In higher organisms (animals, human beings), local toxicity – that is, adverse reactions 
emerging at the application site – is differentiated from systemic toxicity, in which adverse 
reaction appear in an area distant from the application site. Cytotoxicity refers to damage to 
individual cells, for example in cell cultures. Cells can die because of necrosis or apoptosis 
(programmed cell death). 
Immunogenicity is referred to the ability of a substance to provoke an immune response or 
the degree to which it provokes a response. An allergic reaction to a substance can be 
triggered if the organism was previously sensitized to this substance. The concentrations 
that elicit a reaction in a previously sensitized person vary between subjects. The dose levels 
causing allergic reactions are generally significantly lower than those causing toxic 
reactions. 
Genotoxicity describes an alteration of the basepair sequence of the genome DNA. Cells 
possess numerous mechanisms to repair genotoxic damages. Alternatively, a transfer of 
these genetic damages to subsequent generations of cells can be avoided by programmed 
cell death (apoptosis). Nonetheless, if theses genetic damages are passed on to the next 
generation, this effect is called mutagenicity. Mutagenicity and carcinogenicity are not the 
same. Carcinogenicity means that alterations in the DNA have caused a cell to grow and 
divide inappropriately; in other words, alterations of DNA promoted the generation of 
malignant tumors. Carcinogenicity results from several mutations. It is important to 
understand that not all mutagenic events lead to carcinogenesis. However, mutagenicity can 
be assessed as an indicator of “possible” carcinogenicity of substances that directly attack 
DNA. 
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The components of biocompatibility will be discussed in relation to bioceramics later in the 
current chapter. 
3. Bioceramics 
3.1 Definition of bioceramics 
In practical sense, the term bioceramics can be referred to a group of ceramics, which are 
used in the field of biomedicine. These biomaterials are ceramics, which are manufactured 
or processed to be suitable for use in or as a medical device that comes into intimate contact 
with proteins, cells, tissues, organs, and organ systems. 
3.2 Benefits and clinical performance of bioceramics 
Bioceramics are used to restore normal activity of diseased or damaged parts of the body. 
As people age, progressive deterioration of tissues requires replacements in many critical 
applications. After successful researches, various bioceramic products are now 
commercially available in the medical market as substitutes for the original damaged body 
parts and for many other critical applications (Table 2). 
 
Dentistry Dental restorations 
Prosthodontic devices 
Orthodontic brackets 
Repair of periodontal disease 
Maxillofacial reconstruction 
Orthopedics Joint replacements 
Cardiology Prosthetic heart valves 
Neurosurgery Cranioplasty repair 
Otolaryngology Middle ear implants, Vocal cord paralysis 
Miscellaneous Magnetic treatment of bone tumors  
Drug delivery systems 
Table 2. Benefits of ceramics in biomedicine. 
Traditionally, ceramics have seen widescale use as restorative materials in dentistry. Dental 
ceramics are rigid materials that are shaped by sintering, casting, pressing, milling, or 
sonoerosion. Dental ceramics are also available as prefabricated inlays (inserts). Dental 
ceramic restorations include materials for denture teeth, fixed partial dentures, full crowns, 
veneers, inlays, onlays, and post - cores to restore missing tooth part, a tooth, or teeth. 
Restorative dental ceramics could be bonded to metal (Metal-Ceramics) or be metal free 
ceramics (All-Ceramics). High-performance ceramics yield excellent technical properties, 
which make them suitable to be used as copings or frameworks for crowns and bridges. To 
improve their aesthetics, they have to be veneered with other, mainly silicium oxide 
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ceramics. Dental ceramics are further applied as implant materials, for example as coating 
for titanium implants, or as full ceramic implants. The most recent use for ceramics in 
dentistry is orthodontic brackets. The development and demand for these items has been 
driven solely by aesthetics. Also, ceramics are used for repair for periodontal diseases. They 
are also useful for maxillofacial reconstruction, augmentation and stabilization of the jaw 
bone because bioceramics may develop the clinical applications of bone substitutes. The 
physical, chemical and biological properties of bioceramics can be used for preparing 
advanced bone substitutes. Bioactive glass ceramics and calcium phosphate ceramics are the 
two ceramic types used as bone substitute or for bone healing process. Bioactive glass 
ceramics bonds to bone without an intervening fibrous connective tissue interface (Schepers 
et al., 1991). When granules of bioactive glass ceramics are inserted into bone defects, ions 
are released in body fluids and precipitate into a bone-like apatite on the surface, promoting 
the adhesion and proliferation of osteogenic cells (Neo et al., 1993). After long-term 
implantation, this biological apatite layer is partially replaced by bone (Neo et al., 1994). 
Bioactive glass with a macroporous structure has the properties of large surface areas, which 
are favorable for bone integration. The porosity provides a scaffold on which newly-formed 
bone can be deposited after vascular ingrowth and osteoblast differentiation. The porosity of 
bioactive glass ceramics is also beneficial for resorption and bioactivity (De Aza et al., 2003). 
Calcium phosphate polycrystalline ceramic materials can be produced by precipitation from 
aqueous solutions and by solid-state reactions. The rationale for using hydroxyapatite as a 
biomaterial is the advantage of using a material having similar composition and crystalline 
structure as natural calcified tissues. Hydroxyapatite and other calcium-based ceramic 
materials can actively encourage bone regeneration at the surface of an implant. It has been 
postulated that the use of calcium phosphate ceramic biomaterials might replace the use of 
bone grafts. The chemistry of these materials is reasonably well established (Nascimento et 
al., 2007) and significant animal experiments have shown these materials to be both 
biocompatible and bioactive. 
However, bioceramics use in other fields of biomedicine has not been as extensive, 
compared to metals and polymers. For example, in orthopedics, ceramics such as alumina 
(aluminum oxide ceramics) and zirconia (zirconium oxide ceramics) are used for wear 
applications in joint replacements. Bioceramics can now be used for hips, knees, tendons 
and ligaments replacements. In cardiovascular or circulatory system (the heart and blood 
vessels involved in circulating blood throughout the body), problems can arise with heart 
valves and arteries. The heart valves suffer from structural changes that prevent the valve 
from either fully opening or fully closing, and the diseased valve can be replaced with a 
variety of substitutes. As with dental implants, ceramics may be used as pyrolytic carbon 
coatings for prosthetic heart valves (Sarkar & Banerjee, 2010). Less obvious examples of the 
use of ceramics as biomaterials are in neurosurgical cranioplasty repair of the skull bone 
defects, in hand arthroplasty of the metacarpophalangeal joint, in otolaryngology as 
implants in the middle ear, or the use of bioactive glass ceramics in the treatment of vocal 
cord paralysis. Bioactive glass ceramics containing magnetite can be used to kill bone 
tumors when a magnetic field is applied. Ceramics implants can also be used as drug 
delivery systems (Nascimento et al., 2007). 
3.3 Classification of bioceramics 
Based on their chemical reactivity with the physiological environment, bioceramics can be 
broadly categorized in three types (Fig. 1): 
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3.3.1 Bioinert ceramics 
They are such as alumina, result in little or no physiological reaction in the human body and 
tend to exhibit inherently low levels of reactivity which peak in the order of hundreds of 
years. They are attached by compact morphological fixation. 
3.3.2 Surface reactive or bioactive ceramics 
They are such as bioactive glass ceramics (bioglass), react in a positive way with local cells, 
i.e. they directly attach by chemical bonds and have a substantially higher level of reactivity, 
peaking in the order of 100 days. 
3.3.3 Resorbable bioceramics 
They are porous or nonporous structures which are slowly and gradually replaced by bone 
such as tricalcium phosphate, have even higher levels of reactivity, peaking in the order of 
10 days (Shackelford, 2005). 
 
 
Fig. 1. Classification of bioceramics according to biocompatibility 
4. Why is it significant to study biocompatibility of ceramics? 
Biocompatibility of ceramics is a critical issue because of three different reasons. The first is 
that these materials are in intimate contact with human tissues for long terms and cannot be 
removed by the patient. Secondly, biocompatibility is an ongoing process and not a static 
one. For example, it is possible that a dental implant that is osseointegrated today may or 
may not be osseointegrated in the future. Thirdly, it has to be stressed that biocompatibility 
of fixed prosthodontic materials like ceramics is often overlooked because many 
practitioners assume that, if the material is on the market, its biocompatibility does not need 
to be questioned. For example, two systems are currently responsible for standards that can 
be used to document dental products quality: the American National Standard Institute / 
American Dental Association (ANSI/ADA) document No. 41 (1997) and addendum No. 
41A (1982) and the International Standards Organization (ISO) 10993 document (1993). The 
ANSI/ADA and ISO do not require specific biologic tests to approve the quality of a new 
dental material. Rather, they place the responsibility on the manufacturer to present 
evidence for a compelling case for approval. So, it is up to the manufacturer to defend the 
substantial equivalence argument. The evidences used for approval of quality of a dental 
material consist of in vitro tests (cell-culture), in vivo tests (animal experiments), and clinical 
tests (clinical trials of the material). However, it is becoming increasingly impractical to test 
all new materials through all of these stages. The problems of time, expense, and ethics have 
Bioceramics
Bioinert Bioactive Resorbable
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limited the usefulness of this traditional biologic testing scheme. Therefore, companies 
market materials with little clinical experience, and may rely heavily on in vitro and animal 
experiments (Wataha, 2001). 
Although most ceramic materials are generally regarded as being more or less inert, their 
possible effects of degradation products on biological systems must not be overlooked. The 
composition and physical properties of ceramic materials can affect the inertness. Safety 
cannot be inferred from measurements of one ceramic formulation to other compositions or 
conditions. Since bioceramics have been mainly used in dentistry, biocompatibility and its 
relevant properties for ceramics will be mainly discussed in relation to oral health. 
5. Biologically relevant properties 
5.1 Ceramics composition 
It is believed that biologic reactions in general are mainly based on the interaction of a 
substance eluted from a material with a biologically relevant molecule. Thus, the 
composition of a material is of importance for its biocompatibility (Schmalz & Garhammer, 
2002). Different elements in the periodic table of elements can be used in ceramics. The 
diversity of these ceramics makes understanding their biocompatibility difficult, because 
any element in a material may be released and may influence the body. 
Ceramics are commonly described by their composition. However, composition can be 
generally expressed in two ways; either as weight percentage (wt %) of elements or 
percentage of the number of atoms of each element in the material (atomic percentage = at 
%). Weight percentage is the most common way of describing a material's composition, and 
is used by material manufacturers and by standard organizations. However, biologic 
properties are best understood by knowing the atomic percentage composition. Atomic 
percentage better predicts the number of atoms available to be released and affect the body. 
The wt% and at% of a material or an alloy may be substantially different from each another. 
Ceramics could be oxide or non-oxide ceramics. Oxide ceramics in dentistry are primarily 
based on silicon oxide (SiO2), aluminum oxide (Al2O3), and zirconium oxide (ZrO2). Non-
oxides, such as silicon carbide, silicon nitrite, and aluminum nitrite, are of minor importance 
in dentistry due to their black color. Some dental ceramics can be combined, such as an 
Al2O3-ceramic framework veneered with SiO2 ceramic. Lanthanum glass is used as a 
coupling agent, which infiltrates the aluminum oxide framework. Lanthanum glass consists 
of 39% lithium oxide. Additives (such as leucite) are intended to improve the mechanical 
properties of the ceramics, in particular to limit crack propagation. Further additives in 
dental ceramics are fluxing agents and coloring pigments, such as metal oxides, as well as 
fluorescents such as oxides of cesium and samarium. Some calcium phosphate materials are 
regarded as ceramics, too. These substances represent a very heterogeneous group of 
materials, including sintered hydroxyl apatite (HA) with a very low solubility and 
tricalcium phosphate (TCP) ceramics with varying resorption behaviors. Calcium phosphate 
ceramics usually consists of 100% of the respective mineral phase (TCP or HA). 
5.2 Biodegradation and corrosion 
Biological systems may have harmful or destructive effects on bio- materials, classified as 
biodegradation. In the oral environment, this includes not only the process of destruction 
and dissolution in saliva but also chemical/physical destruction, wear and erosion caused 
by food, chewing and bacterial activity. Therefore, it is important to evaluate the material 
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reactivity in the oral cavity, which is governed by thermo-dynamic principles and electro-
chemical reaction kinetics. This means that when a material is placed in the oral cavity, the 
material-saliva system will be driven toward a state of thermo-dynamic equilibrium. At 
equilibrium, the material either will remain stable in its elemental form or oxidize into its 
ionic form (corrosion). Thus, the initially uncharged elements inside the material lose 
electrons and become positively charged ions as they are released into solution. Corrosion is 
a chemical property that has consequences on other material properties, such as esthetics, 
strength, and biocompatibility. From a biocompatibility standpoint, the corrosion of a 
material indicates that some of the elements are available to affect the tissues around it.  
The chemical durability of dental ceramics is basically good. They are commonly regarded 
as insoluble or only very slightly soluble at best. However, the degradation of dental 
ceramics can generally occur because of mechanical forces (wear) or chemical attack 
(solubility in an acidic, neutral, or alkaline environment), or a combination of the two. Some 
calcium phosphate ceramics are internationally engineered for a gradual resorption (TCP). 
The release of substances can generate unwanted effects (biological and mechanical) on one 
hand, or it may promote biocompatibility on the other hand, such as in terms of improved 
bone apposition (bioactivity). The multiphase microstructure of many dental ceramic 
materials results in complicated corrosion modes, as each phase is likely to react 
individually to the corrosive medium. Besides, chemical durability of ceramic materials may 
be influenced by many other factors, such as the chemical character of the corrosive 
medium, the exposure time, and the temperature. For glass ceramics, the initial surface 
reaction is mainly an acid-base reaction in which leaching ions are replaced by H+ ions, the 
result of which will be an alkali-ion-depleted leach layer overlying a permeable gel layer. 
Beneath the alkali-depleted layer, the corrosion process will produce a silica-rich layer, 
offering some protection to the bulk material. However, because of differences in 
composition, microstructure, and local corrosion conditions, the corrosion process is far 
more complicated and may also lead to the partial breakdown of the silicate structure at the 
surface. In addition, glasses high in K2O have been less chemically durable than glasses 
made with soda (Na2O) as an added flux material, whereas the presence of zirconia and 
alumina has shown to improve the chemical durability of glasses. When exposed to 
hydrolysis testing, ultra-low-temperature sintering ceramics displayed higher solubility 
than traditional high-temperature sintering ceramics. However, in repeated hydrolysis tests, 
high- and low-sintering ceramic materials did not react in the predicted manner. Alumina, 
which is regarded as a very stable material, may also undergo compositional changes when 
exposed to a corrosive environment (Milleding et al., 2002). 
5.3 Ion release 
Corrosion, as mentioned before, is always accompanied by a release of elements and a flow 
of current. The release of substances from dental materials is considered to be gradual and 
to occur in small amounts. Evaluation of mass release from dental ceramics is not common 
in the literature, although there are some studies that have demonstrated such mass release. 
The leakage of inorganic ions from ceramics has been found to take place in aqueous media 
and vary with the glass composition and environmental conditions. Under more severe 
conditions (as the concentration of alkali ions increases), the Si-O-Si bonds may be broken, 
and the entire glass structure may be impaired. The reduction in chemical durability is of 
importance, since an increased susceptibility to chemical attack may release ions of the 
elements (K2O.Al2O3.4SiO2), which in certain circumstances, could be considered 
undesirable from a biocompatibility perspective (Milleding et al., 2002). 
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Two dominant mechanisms could be responsible for the aqueous corrosion of alkali-silicate 
glasses: (1) the selective leaching of alkali ions and (2) the dissolution of the glass network. 
At a pH of 9 or less, selective leaching of alkali ions could be the dominant mechanism. This 
mechanism can be controlled by the diffusion of H+ or H3O+ ions from an aqueous solution 
into the glass and the loss of alkali ions from the glass surface. In general, alkali metal ions 
from glass are much less stable in the glass phase than in the crystalline phase and thus 
could be leached more rapidly. 
In contact with saliva or other organic fluids, biomaterials are instantly covered with organic 
films, the composition and properties of which undoubtedly influence the surface corrosion 
process and subsequent bio-reactions. It has been assumed that organic films on ceramic 
surfaces reduce the surface degradation by building up concentration gradients and 
reducing the diffusion of ionic elements through the surface films. In addition, it has been 
found that leaching of inorganic ions can be influenced by pH of the corrosion solutions and 
the ions potential for the complex binding of dissolved glass constituents, resulting in more 
extensive corrosion than indicated by the pH value alone (Milleding et al., 2002). 
Sjögren et al. (2000) tested the release of elements from different dental ceramics (low-
fusing, conventional veneering, press-casting ceramics) into a cell culture medium by 
inductively coupled plasma optical emission spectrophotometry.  They found multiple 
released elements such as aluminum (Al), silicon (Si), sodium (Na), potassium (K), 
magnesium (Mg), and calcium (Ca). Also, Milleding et al. (2002) studied the in vitro ion 
dissolution from glass-phase ceramics, with or without crystalline inclusions, and from all-
crystalline ceramics using the inductively coupled plasma optical emission spectroscopy. A 
large number of inorganic elements leached out from the previous dental ceramics. The 
major leaching elements were sodium and potassium. There were also magnesium, silicon, 
and aluminum. The various glass-phase ceramics displayed significant differences in ion 
release and significantly higher release values than all-crystalline alumina and zirconia 
ceramics. No significant difference in dissolution was found between high and low-sintering 
glass-phase ceramics or between glass-phase ceramics with high volume fractions of 
crystallites in the glass phase in comparison with those with lower crystalline content. 
Logically, it has to be noted that the type of released elements depends on the composition 
of ceramic material itself. From silicon oxide ceramics, silicon, sodium, potassium, boron, 
and aluminum are released into various diluents at different pH values; silicon, sodium, and 
potassium are leached in higher amounts than are aluminum and boron.  Aluminum oxide 
ceramics leach only minimal amounts of ions under physiological conditions. Calcium 
phosphate ceramics release calcium and phosphate into adjacent tissues. Overall, 
hydroxyapatite and fluorine apatite ceramics are less soluble than tricalcium phosphate 
ceramics (Lacefield, 1999). 
6. Types of biocompatibility tests 
Biomaterials are developed in order to evaluate, treat, augment or replace human tissue, 
organ or function. Biocompatibility is the main prerequisite for their safe use as medical 
devices. In order to assess the biocompatibility of a material, it is necessary to do a battery of 
tests, depending on the intended use, location and duration the material is to come in 
contact with the tissues. The evaluation of biocompatibility is dependent not only on the 
tested biomaterial but also on the test method used. So clinicians need to be familiar with 
these methods. Biocompatibility is measured with 3 types of biologic tests: in vitro tests, 
animal experiments and clinical tests (Fig. 2). 
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Fig. 2. Plan of biocompatibility tests in order. 
The common approach when testing the biological behavior of materials is to start with 
simple in vitro tests. If these experiments and investigations of a material’s efficiency deliver 
promising findings, then more comprehensive studies on experimental animals (in vivo 
evaluation) will be performed. Clinical trials (usage tests) are the final step of this evaluation 
process. 
6.1 In vitro tests 
In vitro biocompatibility tests are less expensive ways to survey newly developed materials. 
They simulate biological reactions to materials when they are placed on or into tissues of the 
body. These tests are performed in a test tube, cell-culture dish, or otherwise outside of a 
living organism in which cells or bacteria are generally placed in contact with a material. For 
example, a strain of bacteria may be used to assess the ability of a material to cause 
mutations (the Ames test). The advantages of in vitro biocompatibility tests are, being 
experimentally controllable, repeatable, fast, relatively inexpensive and relatively simple. 
Another major advantage is that these tests generally avoid the ethical and legal issues that 
surround the use of animals and humans for testing. The primary disadvantage of in vitro 
biocompatibility tests is their questionable clinical relevance. 
6.2 Animal experiments 
In animal experiments, the material is placed into an animal, usually a mammal. For 
example, the material may be implanted into a mouse or placed into the tooth of a rat, dog, 
cat, sheep, goat or monkey. Animal models allow the evaluation of materials over long time 
durations and in different tissue qualities (e.g. normal healthy or osteopenic bone) and ages. 
Not only can the tissues in the immediate vicinity be assessed, but, tissues in remote 
locations of the implanted material can also be studied, which is particularly relevant to the 
study of wear particle debris. However, questions arise about the appropriateness of an 
animal species to represent the human response and that they are time-consuming and 
expensive. In animal experiments, ethical concerns and animal welfare issues are very 
important. 
6.3 Clinical tests 
The clinical test is, by definition, the most relevant biocompatibility test. These tests are 
essentially clinical trials of a material in which the material is placed into a human volunteer 
In vitro tests Animal 
experiments
Clinical tsts
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in its final intended use. In a controlled clinical study, test and control materials are 
examined at the same time. Controlled clinical studies possess a higher level of 
significance/evidence compared with studies in which only one material is investigated. 
Biocompatibility data from clinical studies are naturally of special interest for the clinician, 
since the examination was done on the target group of this material (patients). But this 
should not conceal the fact that clinical studies reveal limitations, too. An uncritical transfer 
of such results to patients in daily practice may result in problems, for instance, if data are 
not based on a blinded study. Therefore, at least treatment and subsequent assessment 
should be done by different persons. Many unwanted reactions appear only after chronic 
exposure. But clinical studies – in particular those with new materials – are frequently 
limited to comparatively short periods of time (some are only 6 months). In addition, only a 
small and often strictly selected group of patients is included in the study, for instance in a 
university hospital. The clinical studies are also expensive, time-consuming, extraordinarily 
difficult to control its variables, difficult to interpret and may be legally and ethically 
complex. Clinical tests are done only if satisfactory results are obtained in the in vitro and 
animal experiments. 
7. Systemic toxicity 
7.1 Means of systemic toxicity testing 
Experimental animals are usually used to determine systemic toxicity. Previously, the acute 
lethal dose 50% (acute LD50) was determined as routine. Acute LD50 is the dose required to 
kill half the members of a tested population after specified test duration. Today, other 
methods that are more sparing of animals are used, such as the so-called limit test 
(administration of a fixed dose, e.g., 2,000 mg/kg body weight). The chronic systemic 
toxicity will be determined by administering the material or extract over several months. 
Tests are sometimes extended over the lifetimes of the experimental animals. At the end of 
these studies, survival rates of the animals and patho-histological alterations of the main 
organs will be determined. Further information regarding chronic toxicity is obtained from 
accidents (high exposure level) and based on observations of occupationally exposed 
subjects (e.g., dental personnel) who are often in contact with the “active” unset material. 
7.2 Systemic toxicity related to ceramics 
One fundamental concern about the safety of ceramics used as fixed prosthodontic materials 
is their ability to cause systemic toxicity in the body. A stress must be applied on several key 
concepts that affect this concern. For example, in dentistry, the following should be 
concerned (Wataha, 2000):  
7.2.1 Presence inside the body 
Elements released from a dental fixed prosthodontic material into the oral cavity are not 
inside the body because these elements may gain access to the inside of the body through 
absorption in the gastrointestinal tract, in the oral mucosa, from the skin, or in the 
respiratory system. The mechanism for this absorption depends on the nature of the 
chemical properties of the released elements - whether they exist as ions, as hydrophilic and 
lipophilic compounds, as volatile substances, or as particles. In contrast, elements that are 
released from dental implants into the bony tissues around the implant are, by definition, 
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inside the body. Therefore, elemental release from ceramic implants is thought to be more 
critical systemically than elemental release from dental ceramics used for prosthetic 
restorations. 
7.2.2 Route of access to the body 
The route by which an element gains access inside the body is critical to its biological effect. 
Some elements become more toxic when administered intravenously into mice than when 
administered orally. 
7.2.3 Distribution in the Body 
Any biomaterial, once inside the body, can release ions which can be distributed to many 
tissues by diffusion through tissues, the lymphatic system, or the blood stream. Released 
metallic particles (0.5 to 10.0 um) may also be ingested by cells such as macrophages. Almost 
all dental materials release substances into the oral cavity, from where they may enter the 
human body through different routes, including swallowing of saliva and inhalation, with 
subsequent passage of the epithelial barriers in the gastrointestinal tract or the lungs. These 
substances may, via the blood circulation, be transported to different organs. The oxidation 
state and chemical form of the metallic ions will significantly influence its absorption, 
distribution, retention half-life, and excretion. Ultimately, the body generally eliminates the 
released ions through the urine, feces, or lungs. The application site may thus be in a 
different location from the effect. At the location of the effect, there may be interference with 
the function of the specific organ if the concentration is sufficiently high (systemic toxicity). 
According to the time frame, acute (up to an exposure period of 24 h), subacute (up to 3 
months), and chronic toxicity are differentiated. 
In general, the systemic toxicity of ceramics is considered to be extremely low (Aldini et al., 
2002). In dentistry, only dental laboratory technicians might be exposed to an inhalation of 
ceramic dust due to processing and finishing of dental ceramics that may cause silicosis 
(fibrotic pneumoconiosis). These lung diseases have been observed in workers in the 
ceramic industry who were exposed to ceramic dust for an extended period of time. The risk 
to a dental laboratory technician of developing silicosis due to ceramic dust is currently 
unknown. The patient’s silicosis risk is considered “very minimal” (Mackert, 1992) if 
commonly accepted safety measures, such as dust removal, are followed. On the other hand, 
there is evidence that released metallic ions from fixed prosthodontic materials can and do 
gain access to the body, and these metallic ions may be widely distributed (Wataha, 2000). 
Person-Sjögren & Sjögren (2002) found a statistically significant increase in levels of insulin 
release from the Langerhans cells after exposure to lithium-containing ceramic (Empress 
ceramics). The danger lies in overseeing the possibility that minimal amounts of ions eluted 
due to chemical or mechanical wear might adversely affect the pancreas, or other organs or 
tissues. 
8. Local toxicity 
8.1 Means of local toxicity testing 
Current knowledge about biomaterials-tissue interactions has been gained through 
bioassays in vitro and in vivo. Taking into account biocompatibility tests available in the 
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general field, cytotoxicity assays are of special concern. In vitro studies are mainly 
performed to evaluate the cytotoxicity. A vast number of different in vitro test methods 
exists which include both quantitative and qualitative methods of cytotoxic effect, i.e. cell 
damage or lysis caused by membrane leakage. However, each test method basically 
consists of three components: (a) the biological system, (b) the cell/material contact, and 
(c) the biological endpoint and corresponding recording system. The biological system 
used in in vitro cytotoxicity tests may be (i) organ cultures, (ii) cells in culture or (iii) cell 
organelles. The cell-material contact may be direct; the cells grow next to, or even on the 
test material. In in vitro tests, direct cell/material contact methods simulate the in vivo 
situation in certain instances. In indirect contact, materials and cells are separated by a 
barrier. Eluates derived from a dental material by storing it for a specific period of time in 
a liquid, such as the nutrient medium, may be used for toxicity testing instead of the 
material itself. Besides the description of cell morphology, different biological endpoints 
can be used as indicators for cell damage: membrane effects, cell activity and proliferation 
rate. The cell reaction can be described morphologically as is done with the lysis index in 
the agar overlay test. However, this method is considered to be only qualitative, or at 
most, semi-quantitative in nature. Furthermore, some dental filling materials contain or 
produce considerable amounts of ingredients, which if applied to cells in culture; the 
morphology of the cells will appear to be normal, indicating no cell damage even though 
the cells are no longer vital (Schmalz & Netuschil, 1985). The use of membrane effects, cell 
activity and proliferation rate have no such drawbacks. Membrane effects can be 
demonstrated by dye exclusion (trypan blue). The trypan blue exclusion assay can be used 
to indicate cytotoxicity, where the dead cells take up the blue stain of trypan blue, and the 
live cells have yellow nuclei. Direct cell counting is easy to perform and can be combined 
with a vital stain in order to exclude dead cells. 
8.2 Local toxicity related to ceramics 
Different researches have been performed to study local cytotoxicity of dental ceramics. 
Cobb et al. (1988) investigated the in vitro biocompatibility of porous air-fired opaque 
porcelain with human gingival fibroblasts. Their results indicated that porous air-fired 
opaque porcelain is biocompatible. Then, Josset et al. (1999) studied the reaction of human 
osteoblasts cultured with zirconia and alumina by investigating cellular functions, and 
found that no cytotoxic effect was observed because neither material altered cell growth rate 
in accordance with the absence of any inducing effect on DNA synthesis or proliferation. 
Also, Sjögren et al. (2000) evaluated the cytotoxicity of different types of feldspathic 
porcelain ceramics by using cells from a mouse fibroblast cell line and the agar overlay test, 
Millipore filter test, and MTT (3-(4, 5-dimethylthiazol-2-y1)2, 5-diphenyl tetrazolium 
bromide)-based calorimetric assay. All the ceramics studied were rated “non-cytotoxic”. 
Consistent with the former study, Uo et al. (2003) tested the cytotoxicity of different 
feldspathic, leucite-reinforced glass, and lithium-containing ceramics against human 
gingival fibroblasts that were cultured using extraction solutions of ceramics, with the aid of 
almar blue assay. They found that no ceramic extractions showed any evidence of 
significant cytotoxicity. 
Different implantation studies have been also performed for different types of ceramics in 
different tissues. Silicon oxide ceramic did not cause inflammation after implantation in 
muscle (G. Schmalz & C. Schmalz, 1981). Bioglasses based on silicon oxide were 
osteoconductive and osteoinductive when implanted in bone (Chan et al., 2002). Aluminum 
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oxide ceramic, before and after infiltration with lanthanum glass, was found to cause a 
significantly thicker connective tissue encapsulation and an increased number of 
inflammatory cells 12 weeks after subcutaneous implantation, compared with Teflon and 
titanium (Limberger & Lenz, 1991). On the other hand, aluminum oxide ceramic resulted in 
osseointegration in other studies and thus revealed a good compatibility with surrounding 
bone (Piatelli et al., 1996). There are obviously differences between the compatibility of 
various ceramics, and these may be correlated to different indications and applications and 
different contact with tissue (for example, core ceramic versus implant ceramics). Zirconium 
oxide ceramic showed good osseointegration when implanted in guinea pigs (Aldini et al., 
2002). Calcium phosphate ceramics have been implanted in various animal models. Results 
were heterogeneous according to the materials tested and depended mainly on the 
following parameters: calcium (Ca)/phosphate (P) ratio, chemical purity, removal of organic 
compounds from raw materials, sintering technique, crystal structure (monophase or 
polyphase), and size and type of pores. Numerous macrophages and foreign body giant 
cells were observed histologically during the first weeks after implantation of absorbable 
TCP ceramics. The integration of non-soluble hydroxyl-apatite ceramic in bone without any 
cellular interface (osseointegration) indicates good biocompatibility (Lacefield, 1999). 
Various degrees of ceramic toxicity have been stated. Messer et al. (2003) studied the 
cytotoxicity of feldspathic porcelains, lithium-disilicate ceramics, and leucite-based glass 
ceramics by testing their ability to alter cellular mitochondrial dehydrogenase activity (SDH 
activity) using tetrazolium assay. Their results revealed that dental ceramics are not 
equivalent in their in vitro biologic effect, even with the same class of material and most 
ceramics caused only mild in vitro suppression of cell function to levels that would be 
acceptable on the basis of standards used to evaluate alloys and composites (< 25% 
suppression of SDH activity). However, the lithium-containing ceramics exhibited 
cytotoxicity that would not be deemed biologically acceptable on the basis of prevailing 
empirical standards for dental alloys. Additionally, Pera et al. (2005) investigated the in vitro 
cytotoxicity of different ceramic materials (lithium-containing, aluminous, zirconium, and 
feldspathic ceramics) with the use of MTT testing on mouse fibroblasts. Their results 
revealed that not all tested materials were free from cytotoxicity. Other confirmatory studies 
have been reported by Elias et al. (2002); Yamamoto et al. (2004) who revealed a varying 
ability to induce inhibition of cell proliferation, cytotoxicity (as measured by colony forming 
efficiency) of silica, and alumina components in ceramic materials used for orthopedic 
prostheses. 
It has to be noted that the biocompatibility has been mainly studied for traditional 
feldspathic porcelains. Most newer ceramic materials, such as those for computer aided 
design – computer aided manufacture (CAD-CAM) all-ceramic systems, have not been 
tested for biologic response with the same scrutiny as has been applied to dental casting 
alloys or even traditional ceramics. In vitro studies have reported different mass loss and 
cytotoxicity of some newer formulations of all-ceramic materials. An in vitro study done by 
the author of the current chapter (Elshahawy et al., 2009a) investigated the ion release from 
CAD-CAM leucite-reinforced glass ceramic material into both sodium chloride and lactic 
acid immersing solutions using inductively coupled plasma mass spectroscopy and showed 
that transient exposure of tested material to an acidic environment for one week is likely to 
significantly increase elemental release from it (e.g. aluminum and potassium ions). 
However, the amounts of these released elements (ions) were shown by the author of the 
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current chapter to be not enough to show high evidence of toxicity against cultured 
fibroblasts using the trypan blue assay (Elshahawy et al., 2009b). 
Whatever is the dental material used for fixed prosthodontic appliance, it is nevertheless 
difficult to predict the clinical behavior of a material from in vitro studies, since oral factors 
such as changes in the quantity and quality of saliva, diet, oral hygiene, polishing of the 
material surface, amount and distribution of occlusal forces, or brushing with toothpaste, 
can all influence corrosion to varying degrees. From a biocompatibility standpoint, the 
corrosion of a material indicates that some of the elements are available to affect the tissues 
around it. Therefore, a study was performed by the author of the current chapter 
(Elshahawy et al., 2010) which quantitatively assess the element release from CAD-CAM 
fabricated leucite-reinforced glass ceramic crowns into saliva of fixed prosthodontic 
patients. They revealed the release of silicon and aluminum ions from them after three 
months in service. These released amounts were not enough to produce pronounced 
cytotoxic effects against fibroblasts. 
9. Genotoxicity, mutagenicity, and carcinogenicity 
9.1 Means of testing 
The Ames assay is used worldwide as an initial screen to determine the mutagenic potential 
of new chemicals and drugs. It is perhaps the most rapid, simple, sensitive and economical 
screening test for mutagenicity and has an extensive database and good correlation with 
carcinogenicity. 
The comet assay is a quick, simple, sensitive, reliable and fairly inexpensive genotoxicity test 
which is widely used to evaluate the genotoxic potential of chemical and physical 
substances. Ostling & Johanson (1984) first demonstrated “comets” and described the tails in 
terms of DNA with relaxed supercoiling through a process of electrophoresis (pH 9.5) of 
cells embedded and lysed in agarose on a microscope slide. Later, Singh et al. (1988) used 
alkaline electrophoresis to analyze DNA damage from treatments with X-rays or hydrogen 
peroxide (H2O2). Since then, the worldwide acceptance of Comet assay makes it a good 
assay for detecting DNA damage. 
9.2 Genotoxicity, mutagenicity, and carcinogenicity related to ceramics 
The mutagenicity (genotoxicity) of dental ceramics is not clear due to the lack of research 
focusing on this aspect. Takami et al. (1997) tested the mutagenicity of aluminous (Al2O3) 
ceramic by using Ames assay and tester Salmonella typhimurium strains TA98, TA100 and 
TA1535. Mutagenicity was not induced by extracted samples of the Al2O3 ceramic with and 
without metabolic activation in Salmonella typhimurium strains TA98 and TA1535. Another 
study by Covacci et al. (1999) in which zirconia ceramic stabilized by yttria (Y-TZP) was 
evaluated for mutagenic and carcinogenic potential in the form of discs did not show any 
mutagenic or oncogenic effects in vitro. A study by Noushad et al. (2009) found that dental 
ceramics did not induce any DNA damage after using tester Salmonella strains TA98 and 
TA1537 to detect frameshift mutations whereas using tester strains TA100 and TA1535 to 
detect base-pair substitution mutations.  From previous studies, it is noted that some 
biomaterials are mutagenic to one tester strain while it is not mutagenic to another. Even 
though many investigators have sometimes used just 2 strains to determine the mutagenic 
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potential of biomaterials, it is felt that the use of at least four tester strains as recommended 
by Mortelmans & Zeiger (2000) gives a more definite result. 
Other studies tested the mutagenicity and carcinogenicity of the different components of 
ceramics separately. For example, lithium is a component of certain ceramics. Leonard et al. 
(1995) reviewed the information available on the mutagenicity, carcinogenicity and 
teratogenicity of lithium.  It was concluded that lithium is unlikely to be carcinogenic. 
Weiner et al. (1990) studied the effects of lithium hypochlorite in a series of tests including 
five strains of Salmonella. Lithium was not found to be genotoxic in any of the test systems 
with the exception of an equivocal response in the Chinese hamster ovary/hypoxanthine-
guanine phosphor-ribosyl transferase assay, which was not replicable in a subsequent 
experiment. 
Silica and alumina are main components of ceramics on which genotoxic studies have been 
reported. In one Comet assay, Zhong et al. (1997) indicated that silica and glass fibers can 
induce DNA damage in mammalian cells and that crystalline silica has a higher DNA-
damaging activity than amorphous silica. Simon et al. (2007) assessed the genotoxicity of 
alumina and titanium oxide (TiO2) using the Comet assay and showed that DNA damage 
was limited to single-strand breaks and/or alkali-labile sites and that genotoxicity was 
weak. From previous studies, the genotoxicity of some of the components of dental ceramics 
remains controversial. 
Three decades ago, uranium salts were previously added at a concentration of 1,000 ppm to 
dental ceramics for simulating the natural luminescence of teeth. Because of the 
radioactivity of uranium salts, alternatives are now applied, such as oxides of rare earths. 
Today, radiation of dental ceramics is only due to natural radionuclides (mainly ┙ and ┛ 
emitters) and much below the materials dated back to the times, when uranium salts had 
been added. Feldspathic ceramic specimens showed an activity concentration 
(Uranium/Thorium chains) that is in the same order of magnitude as for the human body. 
No radiation related adverse effects of dental ceramics have been documented in the 
literature (Veronese et al., 2006). Raw materials used for zirconium oxide ceramics (e.g., 
Zirkon, ZrSiO4) may contain contaminants such as thorium and uranium. These 
contaminants generate ┙-, ┚-, and ┛-radiation. However, the effective activity of zirconium 
oxide ceramic was far below the mean value of the annual exposure to natural radiation 
(Piconi & Macauro, 1999). 
So far, no clinical reports have been published that document a carcinogenic effect of certain 
dental ceramic materials in the oral cavity. The long exposure time that is necessary for the 
emergence of a malignant tumor is a very aggravating factor for clinical assessment of 
potential carcinogenic properties. Therefore, it is only possible to draw indirect conclusions 
from other areas (e.g., occupational exposure to chemicals) to a possible carcinogenic effect.  
10. Immunogenicity 
As mentioned before, the term immunogenicity is referred to the ability of a substance to 
provoke an immune response or the degree to which it provokes a response. Sun et al. 
(2009) studied the clinical effects and security of nanometer ceramics artificial bone 
transplantation to treat the bone defect. After follow-up period for 24 months, the artificial 
bone has no immunogenicity, no rejection, does not affect the blood calcium and 
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phosphorus content, and has higher osteogenic activity. According to our knowledge, there 
is no documentation about sensitivity to ceramics. 
Ceramics are rigid materials and therefore generally need to be luted to human hard tissues 
like teeth. There can be allergies/sensitivities to the cements/bonding agents that are 
necessary for the attachment of ceramic fixed prosthodontic restorations. Postoperative 
sensitivities have been observed in a few cases after the (adhesive) luting of ceramics (inlays, 
crowns) (Pallesen & Dijken, 2000; Studer et al., 1996). Also, one thing that may be an issue is 
that if the ceramic fixed prosthodontic restoration is impinging on a vital tissue, e.g. if 
margins of dental ceramic veneers are impinging on what is called the biologic width of 
gingiva (the amount of space under the gum where nothing can be placed) then a chronic 
state of inflammation will ensue. 
11. Conclusion 
1. Substances are released from ceramics into the surrounding tissues; mainly silicon, 
aluminum, potassium. 
2. Systemic toxicity of ceramics is unlikely to occur due to the relatively low amounts of 
released elements such as lithium and lead. 
3. Few ceramics have shown to be cytotoxic in vitro. The clinical relevance of these 
findings remains unclear. 
4. Generally, local toxicity of ceramics is considered as low. However, more cytotoxicity 
researches are needed due to possible exceptions. 
5. Overall, there is no evidence that ceramics cause or contribute to neoplasia in the body. 
6. Ceramics are generally considered as biocompatible materials, although relatively little 
data are available. 
7. Future biocompatibility studies should be performed to study more measurements 
dealing with cells functions such as protein fabrication (e.g. collagen synthesis), 
respiratory and digestive cell functions in a response to elements released from 
ceramics. 
8. Future biocompatibility studies should be also performed to test the combinations of 
the elemental salts released from ceramic materials for the detection of synergistic, 
antagonistic, or additive effects caused by different mixtures of cations. 
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